AVI BioPharma to be Added to Russell 3000 Index.Business Editors, Health/Medical Writers PORTLAND, Ore.--(BW HealthWire)--June 26, 2001 AVI BioPharma, Inc. (Nasdaq:AVII) (Nasdaq:AVIIW) (Nasdaq:AVIIZ) announced today that the company is poised to join the prestigious Russell 3000(R) Index, a financial measure of the most successful large cap and small cap public companies that is used as a benchmark for investors. AVI (Audio Video Interleaved) A Windows multimedia video format from Microsoft. It interleaves standard waveform audio and digital video frames (bitmaps) to provide reduced animation at 15 fps at 160x120x8 resolution. Audio is 11,025Hz, 8-bit samples. was added to the preliminary index list June 8 and is expected to be added to the index July 9 as part of Frank Russell Co.'s annual reconstitution of its U.S. equity indices. It is a financial landmark for companies to be selected for the list because it is determined strictly by market capitalization rankings and style attributes, rather than by subjective opinion or committee. The Russell 3000 Index The Russell 3000 Index is a stock market index of US stocks. The ticker is "RUA" or similar. See Russell Indexes page for main discussion. See also the iShares Russell 3000. represents 98 percent of the U.S. equity market. It measures the performance of the 3,000 largest U.S. companies based on total market capitalization Total Market Capitalization The total market value of all of a firm's outstanding securities. and serves as a model for both passive and active investment strategies. It includes the 1,000 largest large cap companies as well as the top 2,000 small cap companies. The final membership lists for the Russell indices will be posted on the Russell web site July 9. The Russell 3000 stocks are selected from the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. , American Stock Exchange American Stock Exchange (AMEX) Stock exchange in the U.S. Originally known as “the Curb,” it began as an outdoor marketplace in New York City c. 1850. It moved indoors to its present location in the Wall Street area in 1921. , and the NASDAQ. "AVI's debut on the Russell 3000 Index reflects our significant growth," said Alan Timmins, President and Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of AVI BioPharma. "We're pleased to be part of such a successful peer group." Frank Russell Company, one of the world's leading investment management and advisory firms, provides investment advice and funds to institutional investors in more than 30 countries. Russell's investment business employs a manager of managers approach and has more than $66 billion in assets under management Assets Under Management (AUM) is a term used by financial services companies in the mutual fund and money management or investment management business to gauge how much money they are managing. . The company has retainer consulting relationships with clients representing more than U.S. $1 trillion worldwide. Russell is a subsidiary of The Northwestern Mutual Life Insurance Company. Russell is headquartered in Tacoma, Wash. and has offices worldwide. AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using two technology platforms: cancer immunotherapy and gene-targeted drugs. Its lead clinical agent, AVICINE(TM), a therapeutic cancer vaccine, has completed enrollment in a Phase II trial in pancreatic cancer and is in a Phase III pivotal trial in colorectal cancer. The first application of its NEUGENE compounds, Resten-NG, is designed to treat cancer, cardiovascular restenosis and other cell proliferation disorders by inhibiting the production of a cellular transcription factor, the oncogene oncogene Gene that can cause cancer. It is a sequence of DNA that has been altered or mutated from its original form, the proto-oncogene (see mutation). Proto-oncogenes promote the specialization and division of normal cells. c-myc. It is currently in Phase II trial for restenosis and a Phase I/II study for cancer. More information about AVI is available on the Company's web site at http://www.avibio.com. "Safe Harbor" Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of pre-clinical and clinical testing, the effect of regulation by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the Company's Securities and Exchange Commission filings. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion